Enterprise Innovation Institute

N4 Pharma announces collaboration with SRI to target and treat previously unreachable cells in the human body

Posted on: May 9, 2024

N4 Pharma Plc has entered into a research collaboration agreement with SRI to combine its Nuvec delivery system with SRI’s proprietary FOX Three Molecular Guidance System (MGS) with the aim of co-marketing the combined technology.

Read full post: Read More